Expression of p21(WAF1/CIP1) in fetal and adult tissues: Simultaneous analysis with Ki67 and p53

Journal of Clinical Pathology

Volumn 50, Issue 8, 1997, Pages 645-653

  Mateo, M S ^a   Saez, A I ^a   Sanchez Beato, M ^a   Garcia, P ^a   Sanchez Verde, L ^a   Martinez, J C ^a   Orradre, J L ^a   Piris, M A ^a  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

Fetal and adult tissues; Ki67; p21(WAF1 CIP1); p53

Indexed keywords

BCR ABL PROTEIN; KI 67 ANTIGEN; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; ENZYME INHIBITOR; PHYTOHEMAGGLUTININ;

ADULT; ANTIGEN EXPRESSION; ARTICLE; FETUS; FLOW CYTOMETRY; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; TISSUE DISTRIBUTION; CELL CYCLE; ENZYME IMMUNOASSAY; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGY; MALE; METABOLISM; PHYSIOLOGY; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; FEMALE; FETUS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LYMPHOCYTE ACTIVATION; MALE; PHYTOHEMAGGLUTININS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030612115     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.8.645     Document Type: Article

References (32)

1. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-16.
2. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-4.
3. Hunter T, Pines J. Cyclins and cancer III: cyclin D and CDK inhibitors come of age. Cell 1994;79:573-82.
4. Xiong Y, Xhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992;71:505-14.
5. Zhang H, Hannon GJ, Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 1994;8:1750-8.
6. Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994;369:574-8.
7. Li R, Waga S, Hannon GJ, Beach B, Stillman B. Differential effects of the p21 CDK inhibitor on PCNA dependent DNA replication and repair. Nature 1994;371:534-7.
8. Chen J, Jackson PK, Kirschner MW, Dutta A. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 1995;374:386-8.
9. Yang ZY, Perkins ND, Ohno T, Nabel EG, Nabel GJ. The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med 1995;1:1052-6.
10. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
11. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-74.
12. Bae I, Smith ML, Sheikh MS, Zhan Q, Scudiero DA, Friend SH, et al. An abnormality in the p53 pathway following X-irradiation in many wild-type p53 human melanoma lines. Cancer Res 1996;56:840-7.
13. Dulic V, Kaufman WK, Wilson SJ, Tisty TD, Lees E, Harper JW, et al. P53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994;76:1013-23.
14. Michieli P, Chedid M, Lin P, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 a p53-independent pathway. Cancer Res 1994;54:3391-5.
15. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, el-Houseini ME. Induction of p21 (WAF1/CIP1) during differentiation. Oncogene 1994;9:3389-96.
16. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travali S, et al. P53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 1995;55:668-74.
17. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995;267:1018-21.
18. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzlcr K, et al. P53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995;9:935-44.
19. Parker SB, Eichele G, Zhang P, Rawls, Sands, Bradley A, et al. p53-independent expression of p21/Cip1 in muscle and other terminally differentiating cells. Science 1995;267: 1024-7.
20. El-Deiry W, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, et al. Topological control of p21WAF1/ CIP1 expression in normal and neoplastic tissues. Cancer Res 1995;55:2910-9.
21. Doglioni C, Pelosio P, Laurino L, Macri E, Meggiolaro E, Favretti F, et al. p21/waf1/cip1 espression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation. J Pathol 1996;179:248-53.
22. Waf1 Cip1 expression in normal human tissues. Am J Pathol 1996;148:825-35.
23. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1992;13:502-9.
24. Lutzker SG, Levine AJ. A junctionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nat Med 1996;2:804-10.
25. + MDM2 p21-immunophenotype associated with missense p53 mutations. J Pathol [In press.]
26. Chilosi BM, Doglioni C, Magalini A, Inghirami G, Krampera M, Nadali G, et al. P21/waf1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function. Blood 1996;88:4012-20.
27. DiGiuseppe JA, Redston MS, Yeo CJ, Kern SE, Hruban RH. p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am J Pathol 1995;147:884-8.
28. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995;82:675-84.
29. Kip1-deficient mice. Cell 1996;85:733-44.
30. Kip1. Cell 1996;85:721-32.
31. Lee EY-HP, Chang C-Y, Hu N, Wang Y-CJ, Lai C-C, Herrup K, et al. Mice deficient for Rb are nonviable and show effects in neurogenesis and hematopoiesis. Nature 1992; 359:288-94.
32. Szekely L, Jian W-Q, Bulic-Jakus F, Rosen A, Ringertz N, Klein G, et al. Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Differ 1992;3:149-56.